StockData

Oaktree Acquisition Corp. III Life Sciences (OACC) stock

OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)

Close on Nov 17, 2026Market cap $263.53MP/E –Yield –

Earnings

Oaktree Acquisition Corp. III Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Oaktree Acquisition Corp. III Life Sciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Oaktree Acquisition Corp. III Life Sciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Oaktree Acquisition Corp. III Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Oaktree Acquisition Corp. III Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?